Lewis JD - Search Results

1

Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.

Sandborn WJ, Feagan BG, Loftus EV Jr, Peyrin-Biroulet L, Van Assche G, D'Haens G, Schreiber S, Colombel JF, Lewis JD, Ghosh S, Armuzzi A, Scherl E, Herfarth H, Vitale L, Mohamed MF, Othman AA, Zhou Q, Huang B, Thakkar RB, Pangan AL, Lacerda AP, Panes J. Sandborn WJ, et al. Among authors: lewis jd. Gastroenterology. 2020 Jun;158(8):2123-2138.e8. doi: 10.1053/j.gastro.2020.01.047. Epub 2020 Feb 8. Gastroenterology. 2020. PMID: 32044319 Free article. Clinical Trial.

2

Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma.

Lewis JD, Schwartz JS, Lichtenstein GR. Lewis JD, et al. Gastroenterology. 2000 Jun;118(6):1018-24. doi: 10.1016/s0016-5085(00)70353-2. Gastroenterology. 2000. PMID: 10833475 Free article.

3

An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.

Lewis JD, Lichtenstein GR, Stein RB, Deren JJ, Judge TA, Fogt F, Furth EE, Demissie EJ, Hurd LB, Su CG, Keilbaugh SA, Lazar MA, Wu GD. Lewis JD, et al. Am J Gastroenterol. 2001 Dec;96(12):3323-8. doi: 10.1111/j.1572-0241.2001.05333.x. Am J Gastroenterol. 2001. PMID: 11774944

4

Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.

Su C, Salzberg BA, Lewis JD, Deren JJ, Kornbluth A, Katzka DA, Stein RB, Adler DR, Lichtenstein GR. Su C, et al. Among authors: lewis jd. Am J Gastroenterol. 2002 Oct;97(10):2577-84. doi: 10.1111/j.1572-0241.2002.06026.x. Am J Gastroenterol. 2002. PMID: 12385442

5

A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease.

Su C, Lichtenstein GR, Krok K, Brensinger CM, Lewis JD. Su C, et al. Among authors: lewis jd. Gastroenterology. 2004 May;126(5):1257-69. doi: 10.1053/j.gastro.2004.01.024. Gastroenterology. 2004. PMID: 15131785 Review.

6

State of the art: IBD therapy and clinical trials in IBD.

Isaacs KL, Lewis JD, Sandborn WJ, Sands BE, Targan SR. Isaacs KL, et al. Among authors: lewis jd. Inflamm Bowel Dis. 2005 Nov;11 Suppl 1:S3-12. doi: 10.1097/01.mib.0000184852.84558.b2. Inflamm Bowel Dis. 2005. PMID: 16254481 Review.

7

The impact of increased body mass index on the clinical course of Crohn's disease.

Hass DJ, Brensinger CM, Lewis JD, Lichtenstein GR. Hass DJ, et al. Among authors: lewis jd. Clin Gastroenterol Hepatol. 2006 Apr;4(4):482-8. doi: 10.1016/j.cgh.2005.12.015. Clin Gastroenterol Hepatol. 2006. PMID: 16616354

8

Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis.

Osterman MT, Kundu R, Lichtenstein GR, Lewis JD. Osterman MT, et al. Among authors: lewis jd. Gastroenterology. 2006 Apr;130(4):1047-53. doi: 10.1053/j.gastro.2006.01.046. Gastroenterology. 2006. PMID: 16618398

9

A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis.

Su C, Lewis JD, Goldberg B, Brensinger C, Lichtenstein GR. Su C, et al. Among authors: lewis jd. Gastroenterology. 2007 Feb;132(2):516-26. doi: 10.1053/j.gastro.2006.12.037. Epub 2006 Dec 20. Gastroenterology. 2007. PMID: 17258720 Review.

10

Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.

Lewis JD, Lichtenstein GR, Deren JJ, Sands BE, Hanauer SB, Katz JA, Lashner B, Present DH, Chuai S, Ellenberg JH, Nessel L, Wu GD; Rosiglitazone for Ulcerative Colitis Study Group. Lewis JD, et al. Gastroenterology. 2008 Mar;134(3):688-95. doi: 10.1053/j.gastro.2007.12.012. Epub 2007 Dec 7. Gastroenterology. 2008. PMID: 18325386 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,176 results

Search Page